drugset / Trial / NCT01667497

Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?

NCT01667497

Phase 2/3 Completed 60 enrolled London Health Sciences Centre
RandomizedCrossoverTriple-blindTreatment

Summary

Multiple Sclerosis (MS) patients often complain of cognitive fatigue. There is currently no treatment for this symptom. Fampridine SR is a recently approved medication that improves walking ability and walking speed in MS patients. It is thought that it might have the same positive effect on cognitive fatigue. This study will compare fampridine 10mg twice a day to placebo in order to determine if there is any benefit of this medication for cognitive fatigue in MS.

Timeline

Start
2012-09
Primary completion
2015-07
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Dalfampridine Small molecule 10 mg Oral

Indications

No indication recorded.